- Home
- MIRA vs ROMA Comparison
MIRA vs ROMA Comparison
Compare MIRA & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- ROMA
- Stock Information
- Founded
- MIRA 2020
- ROMA 2018
- Country
- MIRA United States
- ROMA Hong Kong
- Employees
- MIRA N/A
- ROMA N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- ROMA Savings Institutions
- Sector
- MIRA Health Care
- ROMA Finance
- Exchange
- MIRA Nasdaq
- ROMA Nasdaq
- Market Cap
- MIRA 26.5M
- ROMA 150.7M
- IPO Year
- MIRA 2023
- ROMA 2024
- Fundamental
- Price
- MIRA $1.29
- ROMA $3.15
- Analyst Decision
- MIRA Strong Buy
- ROMA
- Analyst Count
- MIRA 1
- ROMA 0
- Target Price
- MIRA $17.00
- ROMA N/A
- AVG Volume (30 Days)
- MIRA 804.3K
- ROMA 50.9K
- Earning Date
- MIRA 11-11-2025
- ROMA 09-25-2025
- Dividend Yield
- MIRA N/A
- ROMA N/A
- EPS Growth
- MIRA N/A
- ROMA N/A
- EPS
- MIRA N/A
- ROMA N/A
- Revenue
- MIRA N/A
- ROMA $1,568,345.00
- Revenue This Year
- MIRA N/A
- ROMA N/A
- Revenue Next Year
- MIRA N/A
- ROMA N/A
- P/E Ratio
- MIRA N/A
- ROMA N/A
- Revenue Growth
- MIRA N/A
- ROMA 23.21
- 52 Week Low
- MIRA $0.73
- ROMA $0.54
- 52 Week High
- MIRA $2.56
- ROMA $4.66
- Technical
- Relative Strength Index (RSI)
- MIRA 40.50
- ROMA 56.69
- Support Level
- MIRA $1.19
- ROMA $2.28
- Resistance Level
- MIRA $1.72
- ROMA $3.37
- Average True Range (ATR)
- MIRA 0.10
- ROMA 0.34
- MACD
- MIRA -0.01
- ROMA 0.11
- Stochastic Oscillator
- MIRA 18.25
- ROMA 84.63
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.